X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (61) 61
female (46) 46
male (45) 45
index medicus (42) 42
middle aged (37) 37
adult (34) 34
cardiac & cardiovascular systems (31) 31
transplantation (26) 26
respiratory system (22) 22
surgery (22) 22
aged (20) 20
pulmonary/respiratory (18) 18
treatment outcome (18) 18
heart (16) 16
pulmonary hypertension (16) 16
heart transplantation (15) 15
hypertension (15) 15
care and treatment (14) 14
hypertension, pulmonary - drug therapy (14) 14
adolescent (13) 13
cough (13) 13
evidence-based medicine (13) 13
survival (12) 12
therapy (12) 12
abridged index medicus (11) 11
cardiology and cardiovascular medicine (10) 10
cardiovascular (10) 10
guidelines (10) 10
heart failure (10) 10
mortality (10) 10
antihypertensive agents - therapeutic use (9) 9
double-blind method (9) 9
double-blind (8) 8
health aspects (8) 8
hypertension, pulmonary - physiopathology (8) 8
clinical trials (7) 7
drug therapy (7) 7
follow-up studies (7) 7
medical colleges (7) 7
quality of life (7) 7
sulfonamides - therapeutic use (7) 7
analysis (6) 6
cardiology (6) 6
complications and side effects (6) 6
disease (6) 6
heart-failure (6) 6
hemodynamics - drug effects (6) 6
internal medicine (6) 6
lung transplantation (6) 6
pulmonary arterial hypertension (6) 6
retrospective studies (6) 6
risk factors (6) 6
time factors (6) 6
transplantation of organs, tissues, etc (6) 6
aged, 80 and over (5) 5
bosentan (5) 5
cardiomyopathy (5) 5
diagnosis (5) 5
dose-response relationship, drug (5) 5
endothelin (5) 5
exercise (5) 5
health (5) 5
heart-assist devices (5) 5
hemodynamics (5) 5
hypertension, pulmonary - diagnosis (5) 5
medicine, general & internal (5) 5
patients (5) 5
pulmonary arteries (5) 5
severity of illness index (5) 5
transplants & implants (5) 5
young adult (5) 5
algorithms (4) 4
biopsy (4) 4
cells, cultured (4) 4
classification (4) 4
cohort studies (4) 4
critical care medicine (4) 4
cyclosporine (4) 4
development and progression (4) 4
drug administration schedule (4) 4
drug therapy, combination (4) 4
endothelin receptor antagonists (4) 4
exercise tolerance - drug effects (4) 4
history (4) 4
hypertension, pulmonary - etiology (4) 4
medical research (4) 4
pharmaceutical industry (4) 4
pharmacology & pharmacy (4) 4
prevention (4) 4
prospective studies (4) 4
prostacyclin (4) 4
proteins (4) 4
rapamycin (4) 4
research (4) 4
sildenafil (4) 4
studies (4) 4
survival rate (4) 4
walking (4) 4
administration, oral (3) 3
alzheimers disease (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2010, Volume 29, Issue 8, pp. 914 - 956
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 1, pp. 28 - 37
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2017, Volume 126, pp. 84 - 92
Abstract Objective Pulmonary arterial hypertension (PAH) is a condition which may lead to right ventricular failure and premature death. While recent data... 
Pulmonary/Respiratory | Phosphodiesterase 5 inhibitor | Pulmonary Hypertension | Endothelin A receptor antagonist | Outcome assessment | Combination drug therapy | Ambrisentan | 5 INHIBITOR THERAPY | CARDIAC & CARDIOVASCULAR SYSTEMS | SILDENAFIL | METAANALYSIS | SAFETY | RANDOMIZED CONTROLLED-TRIAL | TADALAFIL | COMBINATION | ENDOTHELIN RECEPTOR ANTAGONIST | RESPIRATORY SYSTEM | ORAL TREPROSTINIL | BOSENTAN | Hypertension, Pulmonary - classification | Outcome Assessment (Health Care) | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Pyridazines - pharmacology | Exercise Tolerance - drug effects | Dose-Response Relationship, Drug | Tadalafil - administration & dosage | Natriuretic Peptide, C-Type - drug effects | Pyridazines - administration & dosage | Tadalafil - pharmacology | Adult | Female | Phenylpropionates - adverse effects | Hypertension, Pulmonary - drug therapy | Phosphodiesterase 5 Inhibitors - therapeutic use | Endothelin A Receptor Antagonists - therapeutic use | Pyridazines - adverse effects | Biomarkers - metabolism | Phenylpropionates - administration & dosage | Treatment Outcome | Antihypertensive Agents - therapeutic use | Survival | Phenylpropionates - pharmacology | Drug Therapy, Combination - methods | Elapid Venoms | Hemodynamics - drug effects | Medical colleges | Medical research | Care and treatment | Medicine, Experimental | Cardiology | Health aspects | Pulmonary hypertension | Complications and side effects | Endothelin | Drug therapy, Combination | Heart | Therapy | Chest | Physical training | Target recognition | Syngeneic grafts | Liver | pH effects | Incidence | Design | Connective tissues | Blood pressure | Diagnosis | Pulmonary arteries | Cut-off | Mortality | Committees | Frost | Physical fitness | Inhibitors | Blood circulation | Nitric oxide | Capillary pressure | Death | Toxins | Hemodynamics | Liver transplantation | Drugs | Diastolic pressure | Medical services | Clinical trials | Clinical outcomes | Contraction | Arteries | Guidelines | Ethics | Dyspnea | Safety engineering | Safety | Drug therapy | Heart diseases | Age | Hypertension | Brain natriuretic peptide | Receiving | Effectiveness | Statistical analysis | Wood | Pharmacology | Adhesion | Coronary artery disease | Nickel | Ventricle | Pharmacokinetics | Respiration
Journal Article
Journal Article